Navigation Links
World Leaders in Alternative Cancer Treatment Join Forces

CHULAVISTA , California, September 23, 2013 /PRNewswire/ --

Two of the world's best known alternative cancer treatment specialists have joined together to offer a combination of their treatments in an exciting new move.

Drs. Donato Perez and Ariel Perez are well respected in their own fields of integrative cancer treatment; IPTLD and Functional Oncology respectively. Until now each physician has worked independently of the other, leading their own team of cancer specialists with remarkable results. However, in this exciting new development, the two physicians have joined forces, to create a cancer treatment program with the potential to achieve even higher success rates.

Functional Oncology is a unique 5 step program that helps to repair a patient's health on a cellular level, optimizing cellular health and boosting the immune system before using natural therapies which weaken and destroy cancer cells. Lead by Dr. Ariel Perez, the long term survival rate for Functional Oncology is at least double that of conventional therapy for all types of cancer. The long term survival rate for Functional Oncology patients with lung cancer is 29% compared to 3% for conventional treatment.

Whilst cancer is caused by a wide range of independent events, Westernized lifestyles undoubtedly contribute to the increase in chronic disease. Aimed at eliminating the potentially harmful toxicity levels within the cells that make it possible for cancer cells to rapidly grow and weaken the immune system, the 5 step program not only helps patients to beat cancer, but helps them to remain in remission.

IPTLD, or Insulin Potentiated Targeted Low Dose Chemotherapy is a program that has been developed over the last 80 years, by Dr. Donato Perez, his father and grandfather before him. There are currently 451 IPTLD certified practitioners worldwide, all of whom have been trained and certified by Dr. Donato Perez himself. Whilst IPTLD is conducted all over the world, Dr. Donato Perez is currently the only certified IPTLD practitioner in Mexico.

The treatment uses insulin and natural medicine to help chemotherapy to target only cancerous cells, whilst magnifying the effect of chemotherapy. Coupled with chemo sensitivity tests to determine the types of drug that each individual's cancer will react to, IPTLD enables patients to experience the undeniable benefits of chemotherapy without poisoning or damaging healthy cells. This practice dramatically reduces the side effects and potentially fatal consequences of chemotherapy, whilst harnessing the cancer killing power of the drug.

Based at Hospital Angeles Tijuana, and part of Angeles Health, Mexico's largest network of private hospitals, Drs. Donato Perez and Ariel Perez will offer patients Functional Oncology, IPTLD or a combination of the two, after assessing each individual patient for their physical condition and stage and type of cancer.

Both treatment programs include detoxification, nutrition and immune support phases but by combining their cancer fighting skills Drs. Ariel Perez and Donato Perez believe that they will see even more spectacular results.

It is beyond doubt that the partnership of these two pioneers of cancer treatment will give patients every chance of survival. This unique collaborative approach could even change the face of cancer treatment in the future, helping the world to beat cancer.

Angeles Health International

Angeles Health is Mexico's largest private hospital network. The company is comprised of 23 state-of-the-art hospitals totaling more than 2,000 beds and 200 operating rooms. Five million patients are treated each year by 11,000 Angeles Health physicians.

The website has been produced by Angeles Health, part of Mexico's largest private hospital network that supports more international patients than any other hospital network in the world.

The functional oncology center, located at the Hospital Angeles Tijuana, is a full-service, state-of-the-art hospital. It is widely recognized as one of the leading hospitals in Baja California. It is the ideal 'home' for the Functional Oncology program, the only full service hospital in Mexico offering integrative medicine.

For further information, please contact:
Angeles Health International
Carlos Zavala
Telephone: 1-866-668-9263
US Direct: (619)-621-2800

SOURCE Angeles Health International
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Global Sedimentation and Centrifugation Market 2012 - 2016: Worldwide Industry Latest Market Share, Growth, Size, Trends, Strategy and Forecast Research Report
2. Novartis marks World CML Day with update on global research program to evaluate whether Ph+ CML patients can live treatment-free
3. Emergent Technologies Selected to Serve 50 of the World’s Most Innovative Companies
4. Green Dot Holdings LLC CEO, Mark Remmert, Joins Industry Thought Leaders to Discuss Holistic Sustainable Design at A Better World by Design Conference
5. Global Biopesticides Market 2012-2016: Worldwide Industry Latest Market Share, Strategy, Growth, Size, Trends and Forecast Research Report 2016
6. Winton Symposiums material world
7. Worldwide Marine Biotech Market 2016
8. Global Scenario, Trends, Industry Analysis, Size, Share And Forecast, 2012-2016 Report Available Online by
9. Global Biomaterials Market 2012-2016: Worldwide Industry Latest Market Share, Strategy, Growth, Size, Trends and Forecast Research Report
10. American Museum of Agriculture Changes Name to Reflect Bayer CropScience’s Agriculture Tradition and World-Class Technology
11. GUARDaHEART to Host Exclusive Event focused on Targeting Heart Disease in Celebration of the World Heart Day Mission
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
Breaking Biology Technology:
(Date:11/18/2015)... Nov. 18, 2015  As new scientific discoveries deepen ... and other healthcare providers face challenges in better using ... patients. In addition, as more children continue to survive ... adulthood and old age. John M. Maris, ... Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
Breaking Biology News(10 mins):